BiotechTube
Home/QuantX Biosciences/Wei Li, Ph.D.
WL

Wei Li, Ph.D.

Interim Chief Executive Officer

QuantX Biosciences

Therapeutic Areas

ImmunologyInflammation

QuantX Biosciences Pipeline

DrugIndicationPhase
STAT6 inhibitorImmunology/Inflammatory diseasesPreclinical
IL-17 inhibitorImmunology/Inflammatory diseasesPreclinical

Leadership Team at QuantX Biosciences

WT
Wayne Tang, Ph.D.
Co-founder, Chief Scientific Officer
YS
Yax Sun, Ph.D.
Co-founder, Chief Technology Officer
GB
Gregory Bell, M.D.
Chief Medical Officer
View full QuantX Biosciences profile